You can buy or sell MNTA and other stocks, options, ETFs, and crypto commission-free!
Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. Read More The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Edited Transcript of MNTA earnings conference call or presentation 10-Aug-20 12:30pm GMT
Q2 2020 Momenta Pharmaceuticals Inc Earnings Call CAMBRIDGE Aug 10, 2020 (Thomson StreetEvents) -- Edited Transcript of Momenta Pharmaceuticals Inc earnings co
-$0.39 per share
-$0.48 per share